ATE464045T1 - Zusammensetzung aus milchsäure und lactoferrin - Google Patents

Zusammensetzung aus milchsäure und lactoferrin

Info

Publication number
ATE464045T1
ATE464045T1 AT05755054T AT05755054T ATE464045T1 AT E464045 T1 ATE464045 T1 AT E464045T1 AT 05755054 T AT05755054 T AT 05755054T AT 05755054 T AT05755054 T AT 05755054T AT E464045 T1 ATE464045 T1 AT E464045T1
Authority
AT
Austria
Prior art keywords
composition
lactoferrin
lactic acid
treatment
prophylaxis
Prior art date
Application number
AT05755054T
Other languages
English (en)
Inventor
Bjoern Andersch
Inger Mattsby-Baltzer
Original Assignee
Nestor Medical Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestor Medical Ab filed Critical Nestor Medical Ab
Application granted granted Critical
Publication of ATE464045T1 publication Critical patent/ATE464045T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Oncology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT05755054T 2004-06-23 2005-06-23 Zusammensetzung aus milchsäure und lactoferrin ATE464045T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0401631A SE528337C2 (sv) 2004-06-23 2004-06-23 Sammansättning innefattande mjölksyra och laktoferrin, eller ett peptidfragment därav, och användning av denna sammansättning för behandling av tillstånd i urogenitalsystemet
PCT/SE2005/000989 WO2006001766A1 (en) 2004-06-23 2005-06-23 Composition comprising lactic acid and lactoferrin

Publications (1)

Publication Number Publication Date
ATE464045T1 true ATE464045T1 (de) 2010-04-15

Family

ID=32768753

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05755054T ATE464045T1 (de) 2004-06-23 2005-06-23 Zusammensetzung aus milchsäure und lactoferrin

Country Status (15)

Country Link
US (1) US20080161234A1 (de)
EP (1) EP1784176B1 (de)
JP (1) JP2008503576A (de)
KR (1) KR20070048170A (de)
CN (1) CN1972683A (de)
AT (1) ATE464045T1 (de)
AU (1) AU2005257722B2 (de)
BR (1) BRPI0512503A (de)
CA (1) CA2571183A1 (de)
DE (1) DE602005020639D1 (de)
NZ (1) NZ552764A (de)
RU (1) RU2398575C2 (de)
SE (1) SE528337C2 (de)
WO (1) WO2006001766A1 (de)
ZA (1) ZA200703166B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100801891B1 (ko) * 2006-11-02 2008-02-12 한상진 천연물질을 이용한 생식기 염증 예방 또는 치료용 약제학적 조성물
BRPI0809330B8 (pt) 2007-03-30 2021-05-25 Laccure Ab uso de um ou mais oligômeros de ácido láctico, e, composição farmacêutica
EP2130531A1 (de) * 2008-06-04 2009-12-09 Rolf Kullgren AB Vaginalzäpfchen enthaltend Laktatsäure
US9125823B2 (en) * 2009-01-23 2015-09-08 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. Controlled release pharmaceutical or food formulation and process for its preparation
KR101133723B1 (ko) * 2009-10-19 2012-04-09 최원석 소금 및 당을 유효성분으로 함유하는 질염 예방 및 치료용 조성물 및 이의 용도
US9011909B2 (en) 2010-09-03 2015-04-21 Wisconsin Pharmacal Company, Llc Prebiotic suppositories
AU2013292179B2 (en) * 2012-07-16 2017-03-30 Combe International, Llc Pharmaceutical compositions containing oligomeric lactic acid
ITMI20122152A1 (it) * 2012-12-17 2014-06-18 Progine Farmaceutici S R L Composizione per uso topico.
EP2992894A1 (de) * 2014-09-05 2016-03-09 Progine Farmaceutici Srl Vaginal formulierungen für die vorbeugung und behandlung von vaginal- und zervikovaginalen infektionen
RU2637649C2 (ru) * 2014-10-30 2017-12-05 Федеральное государственное автономное образовательное учреждение высшего образования "Национальный исследовательский Томский государственный университет" (ТГУ, НИ ТГУ) Способ и реагент-индикатор для рН-метрии вагинальной жидкости
MX2017016991A (es) * 2017-12-20 2019-06-21 Centro De Retina Medica Y Quirurgica S C Formulación para la administración oral de extracto de arándano azul como auxiliar en la conservación de la salud de la película lagrimal en seres humanos.
EP4260869A1 (de) * 2022-04-11 2023-10-18 Reckitt Benckiser Health Limited Zusammensetzung mit einer kombination von lactoferrin und einem sulfatierten polysaccharid

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8603338D0 (sv) * 1986-08-07 1986-08-07 Bjorn Andersch Medel for behandling av tillstand i slidan
DE69220679T2 (de) * 1992-01-23 1997-10-23 Morinaga Milk Industry Co Ltd Antibakterielles mittel und behandlung von gegenständen mit diesem
WO1998006425A1 (en) * 1996-08-12 1998-02-19 A+ Science Invest Ab Treatment and prevention of infections, inflammations and/or tumours with lactoferrin and/or lactoferricin
KR20010071416A (ko) * 1998-06-05 2001-07-28 마키타 키요아키 유산균 함유 조성물, 약품 및 식품
US6240320B1 (en) * 1998-06-05 2001-05-29 Intermedics Inc. Cardiac lead with zone insulated electrodes
JP3439686B2 (ja) * 1999-03-30 2003-08-25 雪印乳業株式会社 鉄強化飲料
IT1317937B1 (it) * 2000-11-17 2003-07-15 Sigma Tau Healthscience Spa Composizione per stimolare le difese immunitarie ed il metabolismo delferro comprendente una alcanoil l-carnitina e lattoferrina.

Also Published As

Publication number Publication date
EP1784176A1 (de) 2007-05-16
WO2006001766A1 (en) 2006-01-05
KR20070048170A (ko) 2007-05-08
CA2571183A1 (en) 2006-01-05
US20080161234A1 (en) 2008-07-03
SE0401631L (sv) 2005-12-24
RU2007102273A (ru) 2008-07-27
SE0401631D0 (sv) 2004-06-23
BRPI0512503A (pt) 2008-03-11
CN1972683A (zh) 2007-05-30
RU2398575C2 (ru) 2010-09-10
EP1784176B1 (de) 2010-04-14
JP2008503576A (ja) 2008-02-07
AU2005257722B2 (en) 2009-03-12
NZ552764A (en) 2010-03-26
ZA200703166B (en) 2008-08-27
AU2005257722A1 (en) 2006-01-05
SE528337C2 (sv) 2006-10-24
DE602005020639D1 (de) 2010-05-27

Similar Documents

Publication Publication Date Title
ATE464045T1 (de) Zusammensetzung aus milchsäure und lactoferrin
ATE551063T1 (de) Verwendung von bifidobacterium longum zur prophylaxe und behandlung von entzündungen
UA90048C2 (ru) Кондиционированная композиция и способ ее получения
MX2009000285A (es) Piperidinas sustituidas que incrementan la actividad de p53 y usos de las mismas.
MX338338B (es) Composiciones y metodos utiles para el tratamiento de enfermedades respiratorias.
EP2175834B8 (de) Glp-1-fc fusionsprotein-formulierung
NZ617196A (en) Activin-actrii antagonists and uses for increasing red blood cell levels
IL190796A (en) Composition containing nucleic acid encoded by anti-osteoclastogenic protein
WO2006013441A3 (en) Use of probiotic bacteria for the preparation of topical compositions for skin protection
MY153198A (en) Inhibitors of protein aggregation
WO2008054208A3 (en) Use of nutritional compositions for preventing disorders
MX341883B (es) Composicion farmaceutica para el tratamiento y prevencion de canceres.
MX2010002716A (es) Uso de slit, nefrina, efrina o semaforina para el tratamiento de enfermedades de cartilago.
MY161844A (en) Monoclonal antibodies against tissue factor pathway inhibitor (tfpi)
WO2007095288A3 (en) Methionine-containing protein or peptide compositions and methods of making and using
MX2007006284A (es) Acidos biariloximetilarenocarboxilicos.
WO2007082068A3 (en) Methods and compositions for treating asthma in human and non human primates
WO2007025977A3 (en) Anti-tnf alpha producing lactic acid bacteria for the treatment of chronic enterocolitis
NZ594814A (en) Peptide that is derived from a milk protein and has an antioxidative effect and also acts as a blood adiponectin level increase promotion and/or decrease inhibition agent
MY138708A (en) Biaryloxymethylarenecarboxylic acids
WO2006135493A3 (en) A composition for wound healing and use thereof
HK1106253A1 (en) Desoxo-nonadepsipeptides
ATE455789T1 (de) Substituierte nonadepsipeptide
IL194353A0 (en) Lysobactin amides
WO2007134118A3 (en) Protein based composition and methods of using same

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties